Latest News

Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.

MDEdge Logo

Novel botulinum toxin type A earns high marks for forehead lines

Aesthetic Authority Logo

Revance Reports Positive Results in Two Phase 2a Studies of DAXI

Medium Logo

Dustin S. Sjuts of Revance Therapeutics: Five Things You Need To Know To Succeed In The Modern Beauty Industry

Neurology Live Logo

DaxibotulinumtoxinA Aims to Be Next Big Post-Stroke Spasticity Treatment

Bloomberg Logo

Bloomberg: Revance Completes Previously Announced Acquisition of HintMD and its Proprietary Fintech Platform for Aesthetic Practices

Modern Aesthetics logo

Modern Aesthetics: Revance’s DaxibotulinumtoxinA for Injection Looks Good in Phase 2 Studies of Forehead Lines and Crow’s Feet

Med Esthetics logo

Data Shows Six Month Duration for Revance DaxibotulinumtoxinA

Neurology Live Logo

Peter McAllister, MD: JUNIPER Trial on DaxibotulinumtoxinA for Spasticity

Thrive Global Logo

Thrive Global: Dustin S. Sjuts of Revance Therapeutics: Why A Leader Should Create Space for Debate